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Amyotrophic lateral sclerosis-linked FUS/TLS alters
stress granule assembly and dynamics
Desiree M Baron1, Laura J Kaushansky1, Catherine L Ward1, Reddy Ranjith K Sama1, Ru-Ju Chian1, Kristin J Boggio1,
Alexandre J C Quaresma2, Jeffrey A Nickerson2 and Daryl A Bosco1,3*
Abstract
Background: Amyotrophic lateral sclerosis (ALS)-linked fused in sarcoma/translocated in liposarcoma (FUS/TLS or FUS)
is concentrated within cytoplasmic stress granules under conditions of induced stress. Since only the mutants, but not
the endogenous wild-type FUS, are associated with stress granules under most of the stress conditions reported to
date, the relationship between FUS and stress granules represents a mutant-specific phenotype and thus may be of
significance in mutant-induced pathogenesis. While the association of mutant-FUS with stress granules is well
established, the effect of the mutant protein on stress granules has not been examined. Here we investigated the effect
of mutant-FUS on stress granule formation and dynamics under conditions of oxidative stress.
Results: We found that expression of mutant-FUS delays the assembly of stress granules. However, once stress
granules containing mutant-FUS are formed, they are more dynamic, larger and more abundant compared to stress
granules lacking FUS. Once stress is removed, stress granules disassemble more rapidly in cells expressing mutant-FUS.
These effects directly correlate with the degree of mutant-FUS cytoplasmic localization, which is induced by mutations
in the nuclear localization signal of the protein. We also determine that the RGG domains within FUS play a key role in
its association to stress granules. While there has been speculation that arginine methylation within these RGG domains
modulates the incorporation of FUS into stress granules, our results demonstrate that this post-translational
modification is not involved.
Conclusions: Our results indicate that mutant-FUS alters the dynamic properties of stress granules, which is consistent
with a gain-of-toxic mechanism for mutant-FUS in stress granule assembly and cellular stress response.
Keywords: Stress granule, Amyotrophic lateral sclerosis, Frontotemporal lobar degeneration, FUS/TLS, Oxidative stress
Background
Mutations in the gene encoding fused in sarcoma/
translocated in liposarcoma (FUS/TLS or FUS), also
known as the heterogeneous nuclear ribonucleoprotein
(hnRNP) P2 [1], are linked to inherited cases of amyo-
trophic lateral sclerosis (ALS) [2,3]. ALS is a fatal neu-
rodegenerative disease characterized by motor neuron
loss, progressive muscle weakening and paralysis [4].
Most ALS-linked FUS mutations are located within the
C-terminal nuclear localization signal (NLS) that binds
transportin, the nuclear importer that translocates FUS
from the cytoplasm into the nucleus [5,6]. Although
FUS is predominately localized to the nucleus in most
cell types [7], it has nucleo-cytoplasmic shuttling cap-
abilities that may be important for mRNA transport [8].
In fact, FUS is thought to play a role in local translation
at the dendrites of neuronal cells [9-11]. Disruption of
the FUS/transportin interaction leads to nuclear deple-
tion with concomitant cytoplasmic accumulation of
FUS in cultured mammalian cells [6]. The potential
relevance of this interaction is underscored by the cyto-
plasmic accumulation of FUS in both ALS [2,3] and
frontotemporal lobar degeneration (FTLD) [12] post-
mortem central nervous system (CNS) tissues.
The extent to which FUS mutants redistribute to the
cytoplasm correlates with ALS disease severity [6,13].
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For example, individuals with the FUS R495X mutation,
which leads to truncation of the NLS and significant
cytoplasmic retention of FUS, exhibit early disease onset
and a relatively severe disease course [13]. Nuclear de-
pletion of FUS may impair putative nuclear functions in-
volving mRNA [14,15] and DNA [16,17] processing. An
alternative, though not mutually exclusive, possibility is
that mutant-FUS exerts a gain-of-toxic function in the
cytoplasm [18].
Recently, a two-hit model has been proposed to ac-
count for cytoplasmic FUS toxicity in ALS and FTLD
[19]. Cytoplasmic mislocalization of FUS, either
through genetic mutations or other unidentified factors,
represents the first hit. The first hit alone may not be
sufficient to cause disease. However, a second hit stem-
ming from cellular stress directs cytoplasmic FUS into
stress granules. Stress granules are stalled translational
complexes that form as a normal response to induced
stressors such as oxidation, heat-shock, viral infection
or hypoxia [20]. The function of stress granules is
thought to be in the triage of mRNAs that are destined
for expression, storage or degradation, which in turn re-
stores cellular homeostasis [21]. Stress granule function
may not be limited to mRNA processing, as the activity
of certain proteins can also be controlled by their se-
questration into stress granules [22]. It follows that the
association of mutant-FUS with stress granules may im-
pair stress response and ultimately cause disease [23].
This notion is supported by evidence of stress granule
marker proteins within the pathological aggregates of
neurodegenerative disease tissues [6,24,25].
While we and others have firmly established a mutant-
specific phenotype with respect to FUS in stress granules
[5,6,13,26-30], there is little evidence that mutant-FUS ac-
tually alters the properties of stress granules. Although
there is no functional assay per se for stress granules, the
properties of stress granules that are thought to be rele-
vant to their function include assembly kinetics, dynamics,
morphology and abundance [21,31]. Under conditions of
oxidative stress, we show that mutant-FUS delays stress
granule formation in mammalian cell culture. Once so-
dium arsenite-induced stress granules are formed, how-
ever, those containing mutant-FUS are more dynamic,
larger and more abundant compared to stress granules
lacking FUS. Upon removal of stress, stress granules disas-
semble more rapidly in cells expressing cytoplasmic
mutant-FUS. Further, we identified the RGG domains
within FUS as playing a key role in the assembly of
mutant-FUS into stress granules, although the methylation
of arginine residues within these RGG domains does not
play a significant role. The evidence presented here sup-
ports the hypothesis that the association of mutant-FUS
with stress granules represents a gain-of-toxic interaction
in ALS pathogenesis.
Results
The expression of cytoplasmic mutant FUS influences
stress granule assembly and disassembly
We and others previously demonstrated that ALS-
linked FUS mutants assemble into stress granules to
an extent that directly correlates with their cytoplasmic
mislocalization [6,13]. These experiments were per-
formed under conditions of acute stress such that stress
granules assembled rapidly and did not address whether
mutant-FUS affects the processes of stress granule as-
sembly and disassembly. First, we employed our previ-
ously characterized, doxycycline-inducible HEK-293 cell
lines expressing GFP-tagged wild-type FUS and ALS-
linked FUS mutants (R495X and H517Q) [13] to exam-
ine the effect of mutant-FUS on stress granule assembly
under conditions of oxidative stress. The R495X muta-
tion truncates the nuclear localization signal (NLS),
causing FUS to significantly redistribute from the nu-
cleus to the cytoplasm (Figure 1A and [13]). On the op-
posite end of the mislocalization spectrum is H517Q, an
autosomal recessive mutation in the NLS that induces a
mild mislocalization phenotype (Figure 1A and [2,13]).
Stress granule assembly was initiated in GFP-FUS
(WT, R495X, and H517Q) cell lines with 0.25 mM so-
dium arsenite, an inducer of oxidative stress [32] and an
environmental toxicant that can cause neural defects
[33,34]. Sodium arsenite has been shown to induce the
incorporation of cytoplasmic FUS-mutants into stress
granules, but does not influence endogenous FUS or ex-
ogenously expressed GFP-FUS WT proteins [13,35]. In
fact there is no difference in cellular response to sodium
arsenite with respect to stress granule formation or cell
viability when FUS expression is reduced [31,35]. There-
fore, sodium arsenite induces a mutant-specific pheno-
type with respect to FUS localization to stress granules.
The concentration of sodium arsenite employed here
was reduced from the 0.5 mM concentration that is typ-
ically used [13,36] in order to lengthen the timescale of
stress granule assembly and resolve differences in this
process between cell lines. Ras GTPase-activating protein-
binding protein 1 (G3BP), a stress granule specific marker
[36], was used to probe for stress granules by immuno-
fluorescence (IF) over a 90 min time course of sodium ar-
senite exposure. At 0 min, there were no stress granules;
G3BP remained diffusely cytoplasmic and no cytoplasmic
GFP-FUS puncta were detected in any cell line (Figure 1A).
By 90 min, all cell lines contained stress granules in virtu-
ally every cell. As expected, GFP-FUS R495X co-localized
with G3BP in stress granules, as did GFP-FUS H517Q al-
beit to a far lesser degree. In contrast, GFP-FUS WT
remained entirely nuclear and was not detected within
these structures (Figure 1A and Additional file 1). Strik-
ingly, fewer GFP-FUS R495X expressing cells contained
G3BP-positive stress granules compared to GFP-FUS (WT
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and H517Q) lines after approximately 40 min of sodium
arsenite exposure (Figure 1A).
Quantification of these results revealed that the
greatest difference in cells containing stress granules oc-
curred between the GFP-FUS R495X (65 ± 3.3%) and
GFP-FUS WT (90 ± 1.5%) lines after 40 min of sodium
arsenite exposure (Figure 1B). Stress granules were also
assembled in GFP-FUS H517Q cells (79 ± 2.5%), though
to a lesser extent than WT cells. Therefore, the expres-
sion of mutant-FUS is not sufficient to cause a delay in
stress granule assembly, but rather, the delay in assembly
depends on the extent that FUS is redistributed to the
cytoplasm (WT<H517Q<R495X). Artifacts from FUS
over-expression are not expected to influence these
results since the expression levels of all exogenous GFP-
FUS proteins were similar to each other and within two-
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Figure 1 Mutant-FUS expression delays the assembly and expedites the disassembly of stress granules in human cells.
(A) Representative fluorescence images of HEK-293 cells expressing GFP-FUS (WT, R495X or H517Q) upon treatment with 0.25 mM sodium
arsenite for 0, 40 and 90 min. The extent of stress granule formation in each line is illustrated with low magnification (40x) images using the
anti-G3BP (red) stress granule marker (columns 1, 3 and 5). The localization of GFP-FUS (green) with respect to the nuclei (DAPI; blue) and stress
granules is demonstrated within high magnification (100x) images (columns 2, 4 and 6). Scale bar = 20 and 5 μm, respectively, in low and high
magnification images. (B) Quantification of the percentage of cells with stress granules at 40 min for the lines in (A) that are either induced (+) or
not induced (−) to express GFP-FUS reveal that expression of GFP-FUS R495X causes a significant decrease in the number of cells with stress
granules compared to controls. All error bars represent SEMs. Statistically significant differences were determined by one-way ANOVA and Tukey’s
post-hoc test (****P < 0.0001, *P < 0.05). Additional significant comparisons include, but are not shown for clarity: uninduced GFP-FUS WT versus
induced GFP-FUS R495X (P <0.001), uninduced GFP-FUS H517Q versus induced GFP-FUS R495X (P <0.001), and induced GFP-FUS H517Q versus
induced GFP-FUS R495X (P < 0.01). (C) Western blot and densitometry analyses of cell lines in (B) and naive HEK-293 cells (UT) reveal that
exogenous (exo) GFP-FUS proteins are expressed at levels similar to each other and within 2-fold of endogenous (endo) FUS (exo/endo FUS
ratio). (D) Stress granule disassembly was assessed as described in (B) for GFP-FUS WT, R495X and H517Q lines after stress was removed for
90 min. Significantly fewer GFP-FUS R495X expressing cells contain stress granules.
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fold of endogenous FUS (Figure 1C). To rule out an in-
herent difference between cell lines irrespective of GFP-
FUS expression, identical experiments were performed
in uninduced cells (i.e., without doxycycline). Uninduced
GFP-FUS (WT and H517Q) lines did not express detect-
able GFP-FUS and behaved similarly to induced GFP-
FUS WT cells, confirming that GFP-FUS WT expression
has no effect on stress granule assembly. There was a
small yet insignificant difference between uninduced
GFP-FUS (WT and R495X) lines (Figure 1B). We sus-
pect this may be due to low levels, below the limit of de-
tection via western analysis (Figure 1C), of GFP-FUS
R495X expression in the absence of doxycycline. None-
theless, induced expression of GFP-FUS R495X in these
cells significantly attenuated the assembly of stress gran-
ules compared to the uninduced condition in the same
line (Figure 1B).
The reversible nature of stress granules is an import-
ant functional feature of these structures; upon removal
of stress, stress granules disassemble as the cell re-
establishes homeostasis. Since mutant-FUS delays the
assembly of stress granules, we sought to determine
whether mutant FUS also influences the reverse process
of disassembly. Cells were treated with 0.25 mM sodium
arsenite for 1 h, at which point ~100% of cells in all cell
lines contained stress granules. The disassembly process
was initiated by replacing sodium arsenite with fresh
media, and the percentage of cells with stress granules
was quantified after 90 min. At this time point, fewer
GFP-FUS R495X expressing cells (51 ± 6.0%) contained
stress granules compared to GFP-FUS WT (72 ± 3.7%)
and GFP-FUS H517Q (68 ± 6.0%). Therefore, expression
of GFP-FUS (WT and H517Q) had virtually no effect,
while expression of the cytoplasmic GFP-FUS R495X
exerted the most pronounced effect on the kinetics of
stress granule disassembly (Figure 1D). Interestingly, a
similar effect on stress granule assembly and disassembly
was observed upon depletion of endogenous TAR DNA-
binding protein 43 (TDP-43) [37], which, unlike FUS, is
thought to play a normal role in arsenite-induced stress
response [31]. Thus, both a loss of TDP-43 function and
a potential toxic gain of mutant-FUS function manifests
in delayed stress granule assembly and more rapid stress
granule disassembly under conditions of oxidative stress.
While HEK-293 GFP-FUS lines are ideal for microscopic
measurements of stress granule properties, owing to the
GFP tag on FUS and the relatively flat nature of these cells,
we wanted to both confirm these stress granule assembly
trends in neuronal cells and rule out a potential “tag effect”
from GFP. To this end, motor neuron-like NSC-34 [38] cell
lines were engineered to constitutively express untagged hu-
man FUS WT or FUS R495X using a lentiviral transduction
expression system. FUS protein expression in these cells was
accomplished with an IRES-containing bicistronic vector
(CSCW2-IRES-GFP), which allowed for the simultaneous
expression of both FUS and GFP separately (i.e., not as a fu-
sion protein) but from the same RNA transcript. Therefore,
GFP served as a reporter for cells transduced to express ei-
ther untagged FUS WT or R495X. The expression levels of
FUS (WT and R495X) proteins were similar to
each other and within two-fold of endogenous FUS
(Figure 2A and Additional file 2). In the absence of
stress, elevated levels of cytoplasmic FUS were observed
in NSC-34 cells expressing FUS R495X, and diffuse
cytoplasmic G3BP signal was observed in both FUS
R495X and WT cells. Upon exposure to 0.25 mM so-
dium arsenite for 1 hr, FUS was detected within G3BP-
positive stress granules only in cells expressing FUS
R495X. Although sodium arsenite exposure lead to
fewer NSC-34 cells with stress granules overall com-
pared to HEK-293 cells, the same phenotype was ob-
served in that fewer cells formed stress granules in FUS
R495X expressing cells compared to those expressing
FUS WT (Figure 2B). Quantification of this phenotype
revealed a 2.4-fold lower percentage of stress granule-
containing NSC-34 cells for FUS R495X (23 ± 1.6%) com-
pared to FUS WT (55 ± 2.8%) lines (Figure 2C). To assess
whether the expression of exogenous human FUS proteins
had any effect on stress response in these cells, the percent-
age of cells with stress granules was also quantified in the
parent, or non-transduced, NSC-34 cell line after 1 h of so-
dium arsenite exposure. While FUS WT and R495X lines
exhibited the most significant difference, there were also
more FUS WT cells with stress granules relative to the par-
ent (37 ± 3.6%) line (Figure 2C). Possible explanations for
why an effect of exogenous FUS WT is observed in NSC-
34 but not HEK-293 (Figure 1B) cells is that the expression
of exogenous human FUS WT exerts an additional stress
due to i) higher relative protein levels (compare exogenous
to endogenous FUS in Figures 1C and 2A), and/or ii) differ-
ent species of cells (expression of human FUS in mouse
versus human cells), either of which could heighten the
stress response of these cells to sodium arsenite. In fact, ex-
pression of FUS WT is sufficient to induce stress and tox-
icity in different model organisms [39-41]. Nonetheless, the
efficiency of stress granule assembly in the parent NSC-34
line is more similar to that of FUS WT than FUS R495X
(Figure 2C). Moreover, one would expect FUS R495X to
also impose an additional stress, and yet stress granule as-
sembly is attenuated in these cells, providing further evi-
dence that expression of mutant-FUS interferes with the
assembly of stress granules under conditions of stress.
Unlike HEK-293 cells (Figure 1), the percentage of
NSC-34 cells containing stress granules never reached
100% in any line, and the FUS WT line always contained
double the percentage of cells with stress granules com-
pared to FUS R495X. This behavior precluded our ability
to perform a similar disassembly analysis as described
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above for HEK-293 cells (Figure 1D), which compared
the absolute percentage of cells with stress granules at
different time points.
The expression of cytoplasmic mutant-FUS alters the
dynamic binding properties of stress granule-associated
proteins
Stress granules are highly dynamic structures [32,42,43].
Proteins and mRNA continuously shuttle in and out of
stress granules, reversibly binding to other stress granule
components in a manner that is thought to regulate both
protein signaling activity [22] and mRNA fates towards
translational arrest, expression or decay [20]. To study the
effect of stress granule-associated mutant-FUS on the dy-
namic properties of stress granules, we employed fluores-
cence recovery after photobleaching (FRAP). FRAP
measures the relative kinetics and affinities of protein bind-
ing within complexes, such as stress granules, over the
time course of the experiment [44,45]. Because FRAP
reports on binding events in live cells, fluorescently
tagged-proteins were employed for these experiments
[32,42,43,46]. We transiently expressed monomeric RFP
(mRFP)-tagged proteins T-cell-restricted intracellular
antigen-1 (TIA-1) or G3BP, two established stress granule-
associated proteins, to mark stress granules for FRAP
within HEK-293 GFP-FUS (WT and R495X) cells.
Overexpression of G3BP is sufficient to form inclusions
that resemble stress granules in the absence of stress
[31,47]. Since it is not clear whether these G3BP
overexpression-induced stress granules have different
properties than sodium arsenite-induced stress granules,
conditions were optimized for transfection of mRFP-
G3BP that minimized the formation of G3BP-positive in-
clusions a priori of sodium arsenite treatment (Figure 3A;
see Materials and methods).
During a FRAP experiment on stress granules, the
fluorescence from a tagged species (GFP-FUS R495X,
mRFP-TIA-1 or mRFP-G3BP in our case) is bleached.
The fluorescence signal recovers as bleached molecules un-
bind from sites in the stress granules, un-bleached fluores-
cent molecules exchange back into the photobleached area
and then bind. The fluorescence recovery time is limited by
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Figure 2 Expression of the FUS R495X mutant interferes with stress granule assembly in neuronal cells. (A) Exogenous human (h) FUS
proteins are similar to each other and within 2-fold of endogenous mouse (m) FUS as determined by western blot and densitometry analyses.
The ratio of hFUS/mFUS proteins is indicated for each cell line. (B) Immunofluorescence images of NSC-34 cells expressing untagged FUS (WT
and R495X) either in the absence (−) or presence (+) of 0.25 mM sodium arsenite (SA) for 1 hr. Low magnification (40x) images of SA (+) treated
cells using the anti-G3BP stress granule marker (green) show a greater number of stress granule-positive cells (denoted by arrows) in the FUS WT
line compared to the FUS R495X line. High magnification (100X) images showing a single cell reveal the localization of FUS (red) and G3BP (note:
the far red channel was used for detection of G3BP and the images are shown in green for clarity) under all conditions. DAPI (nuclei) is included
in the overlay images. Note that in cells with stress granules, cytoplasmic R495X co-localizes to these structures as expected (see overlay image in
bottom right). Scale bar = 20 and 5 μm, respectively, in low and high magnification images. (C) Quantitative analysis (as described in Figure 1B)
of the percentage of NSC-34 cells with stress granules after 1 hr of sodium arsenite treatment revealed that expression of FUS R495X inhibited
stress granule assembly compared to cells expressing FUS WT and the parent line. All error bars represent SEMs. Statistically significant differences
were determined by one-way ANOVA and Tukey’s post-hoc test (****P < 0.0001, ***P < 0.001, **P < 0.01).
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either diffusion, which is faster than the rates we report
here, or by binding kinetics; thus, proteins that are tightly
bound to other proteins or cellular structures exhibit rela-
tively long half times of fluorescence recovery (t1/2) [44].
The population of fluorescent molecules that exchange
with their bleached counterparts over the time course of
the experiment comprise the “mobile fraction” [44]. The
“immobile fraction” is the population that is tightly bound
and does not exchange over the time course of the experi-
ment. Here, each experiment was carried out such that the
photobleaching occurred in only a single channel and fluor-
escence was diminished evenly over the entire stress gran-
ule (Figure 3B). Initially, the dynamics of GFP-FUS R495X
within stress granules were investigated since the dynamic
binding properties of this protein under stress conditions
have not been reported. GFP-FUS R495X cells alone or
transfected with either mRFP-G3BP (Figure 3A) or mRFP-
TIA-1 (Figure 3B) were exposed to 0.20 mM sodium arse-
nite for 1 hr, at which point the majority of cells contained
fully formed stress granules. The fast recovery (t1/2 of 3.6 ±
2.1s; Figure 3C) of GFP-FUS R495X by FRAP shows that
this protein re-binds within stress granules relatively
quickly compared to other stress granule-associated pro-
teins (see below). Moreover, ~87% of GFP-FUS R495X
molecules constituted the mobile fraction, indicating that
GFP-FUS R495X is weakly bound within stress granules
(Figure 3D). Neither the t1/2 nor the mobile fraction of
GFP-FUS R495X changed significantly upon transient
transfection of either mRFP-G3BP or mRFP-TIA-1
(Figure 3C and D). Therefore, neither the process of
transient transfection itself, nor the over-expression of
stress-granule associated proteins, influenced the dy-
namic properties of mutant-FUS.
Next we performed FRAP on mRFP-G3BP or mRFP-
TIA-1 to determine the effect of mutant-FUS on the dy-
namic properties of proteins within stress granules.
Fluorescence recovery for mRFP-G3BP (t1/2 12 ± 4.4s;
70 ± 2% mobile) and mRFP-TIA-1 (t1/2 12 ± 3.9s; 78 ±
2% mobile) within GFP-FUS WT expressing cells was
observed (Figure 3E and F). Our measurements of
mRFP-TIA-1 in control HEK-293 cells were similar to
those reported for GFP-TIA-1 COS7 cells [32]. In cells ex-
pressing GFP-FUS R495X, the fluorescence recovery half
times were nearly the same for mRFP-G3BP (t1/2 11 ±
2.8s) and mRFP-TIA-1 (t1/2 10 ± 2.8s). However, the mo-
bile fraction for both mRFP-G3BP and mRFP-TIA-1 in-
creased significantly in GFP-FUS R495X cells to 79 ± 3%
and 89 ± 4%, respectively, compared to GFP-FUS WTcells
(Figure 3E-G). Control experiments in GFP-FUS WT (in-
duced and uninduced) and GFP-FUS R495X (uninduced)
cells confirmed that an increase in mRFP-TIA-1 mobile
fraction required the expression of mutant-FUS (Figure 3G).
The increased mobile fraction for mRFP-G3BP and
mRFP-TIA-1 indicates that these proteins bind more
weakly to factors within GFP-FUS R495X positive stress
granules compared to stress granules lacking mutant-FUS.
As a result, there is increased exchange of mRFP-G3BP
and mRFP-TIA-1 between the area that is photobleached
and the area that is not photobleached, resulting in fluor-
escence recovery. Together, these data demonstrate that
the incorporation of mutant-FUS into sodium arsenite-
induced stress granules decreases the binding of other
stress granule-associated proteins within these structures.
Because we and others observed that stress granules
form as a result of G3BP overexpression [31,47], we exam-
ined whether their dynamic properties were different com-
pared to those stress granules induced by sodium arsenite.
mRFP-G3BP exhibited significantly weaker binding (i.e.,
larger mobile fraction, P < 0.05) within stress granules in
GFP-FUS WT cells under conditions of G3BP over-
expression compared to sodium arsenite stress, indicating
that the dynamic properties of these stress granules are
inherently different (Additional file 3). The most striking
difference was the effect of mutant-FUS: GFP-FUS R495X
significantly increased mRFP-G3BP binding within stress
granules (i.e., smaller mobile fraction) under conditions
of G3BP over-expression compared to all other conditions,
which is the opposite trend in sodium arsenite-induced
stress granules (Figure 3). Therefore, the effect of GFP-FUS
R495X on the dynamic properties of stress granules
(See figure on previous page.)
Figure 3 GFP-FUS R495X is weakly bound to stress granules and alters binding of stress granule-associated proteins. (A) Live cell
images of GFP-FUS (WT and R495X) expressing HEK-293 cells transfected with mRFP-G3BP. Images are shown before (−) and after (+) treatment
with 0.2 mM sodium arsenite (SA) for 1 hr. Scale bar = 10 μm. (B) Top three panels: exemplar GFP and mRFP images of a SA treated cell for a
mRFP-TIA-1 FRAP experiment before and after photobleaching. The mRFP signal, but not GFP signal, is lost from the stress granule (indicated by
arrow). Scale bar = 5 μm. Bottom four panels: fluorescence intensity profiles corresponding to the above panels (rotated 90° clockwise). (C) The
recovery curve for GFP-FUS R495X in untransfected (UT; green triangle) cells are indicative of fast fluorescence recovery. The GFP-FUS R495X
profile does not change upon transfection with either mRFP-G3BP (blue circle) or mRFP-TIA-1 (red square). (D) Nearly identical mobile fractions
support the conclusions in (C). (E & F) Recovery curves for mRFP-G3BP (E) and mRFP-TIA-1 (F) differ for GFP-FUS WT (blue circle) and R495X (red
square) expressing cells. (G) Mobile fractions for the curves in (E & F) are significantly higher for GFP-FUS R495X (black bars) relative to GFP-FUS
WT (white bars) cells. Mobile fractions for mRFP-TIA-1 are the same for the following control experiments: GFP-FUS WT expressing cells (white
bars), uninduced (UI) GFP-FUS WT cells (grey bar) and uninduced GFP-FUS R495X cells (hatched bar). Asterisks indicate statistically significant
differences between cell lines as determined by two-way ANOVA and Tukey’s post-hoc test (****P < 0.0001) on data from at least n=2
independent experiments. All error bars represent SEMs. The total number (N) of stress granule analyzed is indicated on the recovery panels.
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depends on the stressor and is consistent with observations
that the source of stress influences the constituents within
stress granules [48]. Irrespective of the stress, our results
show that the incorporation of GFP-FUS R495X into stress
granules alters the dynamic binding interactions of other
well-characterized stress granule-associated proteins within
in these structures.
Expression of mutant-FUS increases the size and
abundance of stress granules
In addition to dynamics, stress granule size and abun-
dance could also be altered by the presence of mutant-
FUS. As such, both stress granule size and abundance
were quantified in HEK-293 cell lines expressing either
GFP-FUS (WT or R495X) after exposure to 0.5 mM so-
dium arsenite for 1 hr, at which point stress granules
were fully formed (>95% of cells contain stress gran-
ules). In contrast to previous methods that measure the
area of stress granules, which does not take into account
the three-dimensional aspect of these structures, we de-
veloped a method to quantify the volume of stress gran-
ules based on fluorescence intensity measurements (see
Materials and methods). Briefly, fixed cells were labeled
with an anti-G3BP antibody and then optically sec-
tioned by confocal microscopy. Three-dimensional re-
construction of these sections allowed us to quantify
the volume of selected stress granules (Figure 4A). This
analysis revealed that GFP-FUS R495X expressing cells
produced significantly larger stress granules (3.8 ± 0.1
μm3) compared to GFP-FUS WT cells (2.7 ± 0.2 μm3;
Figure 4B and C). This trend is consistent with ALS-
linked TDP-43 mutants, which also show an increased
stress granule size under conditions of hyperosmolar
stress [49], suggesting that this may be a common
disease-related characteristic.
Our quantitative analysis also revealed that mutant-FUS
expressing cells contained 27% more stress granules per
cell (8.8 ± 0.3) compared to WT-FUS (6.9 ± 0.4; Figure 4B
and D). This result is consistent with a recent report dem-
onstrating a greater abundance of stress granules within
patient FUS (R521C and R514G) fibroblast lines under
conditions of sodium arsenite relative to control lines [30].
Moreover, cells expressing ALS-linked TDP-43 also pro-
duce more stress granules compared to control cells under
stress [25]. Therefore, disease-causing FUS and TDP-43
proteins appear to alter stress granules morphology by in-
creasing their size and abundance.
The RGG domains play a key role in modulating the
association of mutant-FUS with stress granules
In order to understand the factors modulating the incorp-
oration of mutant FUS into stress granules, we engineered
GFP-tagged FUS constructs lacking the functional do-
mains of FUS and tested their ability to incorporate into
stress granules. The functional domains of FUS are as
follows: the prion-like QGSY-rich region (QGSY), a
glycine-rich region (GLY), an RNA recognition motif
(RRM), and two arginine-glycine-glycine-rich domains
(RGG1 and RGG2) separated by a C2-C2 zinc finger
motif (ZF) (Figure 5A). All of these domains have been
shown to play a role in modulating the incorporation of
other RNA binding proteins into stress granules [26,50-52]
and thus each have the potential to influence the associ-
ation of mutant-FUS with stress granules. The extent with
which FUS mutants localize to arsenite-induced SGs corre-
lates with their level of cytoplasmic expression (Figures 1, 2
and [13]). However, since transient transfection of highly
cytoplasmic FUS mutants (e.g., R495X) has the potential to
produce cytoplasmic protein aggregates that could con-
found our stress granule analysis [13], domain deletion con-
structs were engineered within the background of the less
aggregation-prone R521G mutant.
Transient transfection of GFP-FUS R521G deletion con-
structs in HeLa cells resulted in varying degrees of GFP-
FUS cytoplasmic expression: FL, ΔQGSY, ΔRGG1, ΔGLY
and ΔRRM were predominately expressed in the nucleus,
whereas relatively high cytoplasmic expression was ob-
served for ΔRGG2, which lacks part of the signal used for
nuclear import of FUS [5] (Figure 5B). Deletion of the zinc
finger motif resulted in a construct that failed to express
in mammalian cells (data not shown), possibly because
this construct is unstable and/or structurally altered [53].
Although GFP-FUS R521G exhibits cytoplasmic expres-
sion upon transient transfection [2], the levels here were
not sufficient for an accurate stress granule analysis. It
was therefore necessary to increase the cytoplasmic ex-
pression of FUS-deletion constructs by co-transfection
with maltose binding protein (MBP)-tagged M9M. M9M
is a transportin/Kapβ2-specific nuclear import inhibitor
that blocks the nuclear import of FUS [6,54]. Co-
transfection with MBP-M9M increased cytoplasmic reten-
tion of GFP-FUS for all constructs, ensuring that each
construct had equal potential to assemble into stress gran-
ules (Figure 5B).
Administration of 0.5 mM sodium arsenite for 1 hr in-
duced stress granule formation (Figure 5B) in ~75% of cells
for all constructs. A ratio of the GFP signal within stress
granules relative to the diffuse GFP-FUS signal in the cyto-
plasm (stress granule/diffuse FUS signal) was used to quan-
tify the incorporation of each construct within stress
granules. Full length GFP-FUS R521G exhibited a robust
localization to stress granules with a stress granule/diffuse
FUS ratio of 4.75 +/− 0.97 (Figure 5B and C). As expected
for a protein that does not associate with stress granules,
analysis with free GFP as a negative control produced the
lowest ratio of 1.13 +/− 0.11. GFP-FUS R521G ΔQGSY,
ΔGLY, and ΔRRM were not significantly different from FL
GFP-FUS R521G. In contrast, deletion of the RGG1
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domain (ΔRGG1) significantly impaired the localization of
FUS into stress granules (1.72 +/− 0.22), and deletion of
the RGG2 domain (ΔRGG2) exhibited a similar impair-
ment trend (2.23 +/− 0.48). We note that while distinct
FUS-positive stress granules are observed for ΔRGG2, a
comparatively high level of GFP-FUS signal remains dif-
fuse, yielding a low stress granule/diffuse FUS ratio. All
constructs were expressed at comparable levels (Figure 5D)
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Figure 4 Stress granule size and number are increased in GFP-FUS R495X expressing cells. (A) Clockwise order: representative
single-plane phase (top left) and anti-G3BP (stress granule marker; red) immunofluorescence (top middle) confocal images of an HEK-293
cell expressing GFP-FUS WT treated with 0.5 mM sodium arsenite for 1 hr. Three-dimensional (3D) reconstruction was used to quantify stress
granule volume (see Materials and methods, and C within this figure). The xy (right) and yz (bottom; view along arrow in xy image) planes
for this 3D reconstructed image are shown; the stress granule highlighted in yellow is marked for volume analysis. Scale bar = 10 μm.
(B) Representative maximum projection confocal images of GFP-FUS WT and GFP-FUS R495X expressing cells treated as in (A) exemplify the
size and number of stress granules for each line. Scale bar = 10 μm. (C and D) GFP-FUS R495X expressing cells contain stress granules with
larger volume (C) and in greater abundance (D) relative to cells expressing GFP-FUS WT. Asterisks indicate statistically significant differences
between cell lines as determined by the Student’s t-test (**P < 0.01, *P < 0.05) on data from n=3 independent experiments. All error bars
represent SEMs.
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and a threshold was applied (see Materials and methods)
such that all cells included in this analysis expressed similar
levels of FUS. Together, these data demonstrate that the
RGG domains in FUS are the most important for mutant-
FUS localization to stress granules.
Methylation of mutant-FUS is not required for its
assembly into stress
In light of the 20 dimethylated arginine residues within
the RGG domains of FUS [55], and the fact that arginine
dimethylation dictates protein and RNA interactions as
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Figure 5 The RGG domains modulate the incorporation of FUS into arsenite-induced stress granules. (A) Illustration of full length (FL) GFP-FUS
R521G and constructs lacking the following sequences: Gln-Gly-Ser-Tyr-rich (ΔQGSY), Gly-rich (ΔGLY), RNA recognition motif (ΔRRM), and Arg-Gly-Gly-
rich (RGG) regions (ΔRGG1 and ΔRGG2). (B) Confocal images of HeLa cells transfected with GFP-FUS R521G constructs (green) alone (−) or co-
transfected (+) with MBP-M9M, the transportin-1 inhibitor. Note the increased levels of cytoplasmic GFP-FUS in co-transfected cells (compare columns
1 and 2). Confocal fluorescence images of co-transfected cells treated with 0.5 mM sodium arsenite for 1 hr were used to assess the ability of GFP-FUS
R521G constructs (green; column 3) to associate with stress granules (G3BP; red; column 4). The greatest degree of GFP and G3BP co-localization was
observed in cells expressing FL GFP-FUS R521G, whereas there was minimal co-localization in control cells expressing free GFP (compare panels in
column 5). (C) Quantitative analysis (see Materials and methods) of (B) reveals that constructs lacking RGG domains (ΔRGG1 and ΔRGG2) exhibit
impaired localization to stress granules. Statistically significant comparisons include FL and ΔRGG1 (*P < 0.05), FL and GFP (**P < 0.01), and ΔQGSY and
GFP (*P < 0.05; not shown on graph for clarity) by one-way ANOVA followed by a Dunnett’s post-hoc test on n=3 independent experiments. All error
bars represent SEMs. (D) Western blot analysis of HeLa cells in (B) demonstrates equivalent expression levels for all GFP-FUS R521G constructs.
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well as protein subcellular localization [56], we explored
the possibility that arginine dimethylation of mutant-
FUS regulates its association with stress granules. While
methylated FUS has been detected within stress granules
in cell culture and pathological CNS inclusions from
individuals harboring FUS mutations [5], it is not clear
whether methylation is actually required for FUS incorp-
oration into these structures. To investigate this ques-
tion, HeLa cells were pre-treated with the global
methyltransferase inhibitor adenosine 2,3-dialdehyde
(AdOx) [57] prior to expression of the highly cytoplas-
mic GFP-FUS R495X mutant and sodium arsenite ex-
posure. We note that conditions (see Materials and
methods) were used to minimize GFP-FUS R495X ag-
gregation in these experiments. Immunoprecipitation of
GFP-FUS R495X using an anti-GFP antibody, followed
by western analysis with the dimethyl-specific ASYM24
antibody, confirmed that GFP-FUS R495X is hypo-
methylated in the presence of AdOx (Figure 6A). Des-
pite the significant degree of hypomethylation, GFP-FUS
R495X maintains a robust association with stress gran-
ules under these conditions (Figure 6B and C). Con-
versely, the overall ASYM24 signal, including the signal
within stress granules, is significantly attenuated. Similar
results were seen in our stable HEK-293 GFP-FUS
R495X line (data not shown). While the small popula-
tion of methylated GFP-FUS R495X that remains after
AdOx treatment (Figure 6A) could be sequestered into
stress granules, the significant decrease in ASYM24 sig-
nal (i.e., the decrease in signal for methylated proteins)
with no decrease in GFP-FUS signal argues against this
possibility. Therefore, while methylated mutant-FUS can
assemble into stress granules, this post-translational
modification is not a prerequisite for its incorporation.
Discussion
The association of cytoplasmically mislocalized ALS-
linked FUS mutants with stress granules is well established
[5,6,13,26-30], but what affect does mutant-FUS have on
the properties of stress granules? We sought to examine
the effect of mutant-FUS on the physical properties of
stress granules that are potentially linked to function.
While there is no functional assay per se for stress gran-
ules, they are believed to represent sites of mRNA triage,
which influences whether particular mRNA transcripts are
retained within stress granules, translated on ribosomes or
degraded within P-bodies [20]. There is also evidence that
the signaling activity of proteins can be controlled by their
sequestration and/or release from stress granules during
stress [22]. Thus, the cellular response to stress is modu-
lated, at least in part, by stress granules. Since mutant-
FUS, but not WT-FUS, is incorporated into stress granules
under various induced stressors, the mutant protein has
the potential to disturb stress granules and impair cellular
stress response in ways that could contribute to ALS
pathogenesis [19].
Stress granules assemble in response to induced stress.
Our results show that ALS-linked, cytoplasmic FUS
R495X delays the assembly of stress granules in both HEK-
293 (Figure 1) and neuronal NSC-34 (Figure 2) cells under
conditions of acute oxidative stress. The predominantly
nuclear FUS H517Q mutant also delays stress granule as-
sembly, but to a lesser degree than FUS R495X (Figure 1).
Therefore, the delay in stress granule assembly correlates
with cytoplasmic levels of mutant-FUS, probably because
the protein is poised to enter stress granules once stress is
induced. Since over-expression of some ALS-FUS mutants
reportedly induce the spontaneous formation of cytoplas-
mic inclusions that stain positively for stress granule
markers [28,29], one might expect the expression of
mutant-FUS to correlate with a faster rate of stress granule
assembly. However, the properties of stress granules are
influenced by the nature of the induced stressor [48], and
we show that stress granules induced by protein over-
expression exhibit different dynamic properties than those
induced by sodium arsenite (Additional file 3). We also
demonstrate that mutant-FUS accelerates the disassembly
of stress granules (Figure 1D). Therefore, expression of
mutant-FUS appears to disfavor the formation of and/or
destabilizes stress granules, possibly by interfering with
protein interactions within these structures (Figure 3). The
effects of mutant-FUS on stress granule assembly and dis-
assembly are reminiscent of effects seen during TDP-43
knock-down [37]. Considering that stress granule assembly
is a regulated process [20], factors that either delay or ac-
celerate stress granule assembly/disassembly may adversely
affect cellular homeostasis.
Interestingly, once stress granules are formed, mutant-
FUS exerts an effect on both stress granule morphology
and abundance that may appear counterintuitive based on
the effect of FUS during the processes of assembly and
disassembly. While the expression of GFP-FUS R495X
both disfavors stress granule assembly and weakens stress
granule associated interactions, under conditions of per-
sistent stress the size and abundance of stress granules is
augmented by the expression of mutant-FUS (Figure 4).
This increased size and abundance of stress granules does
not necessarily mean these structures are held together
more tightly, but rather is a likely consequence of the add-
itional protein load associated with these structures from
the GFP-FUS R495X protein itself. This rationale may also
be relevant to the increased size of stress granules in ALS-
linked TDP-43 mutants under conditions of hyperosmolar
stress [49] and suggests that this phenotype may be part of
a common disease pathway. An intriguing, but not mutu-
ally exclusive, possibility is that mutant-FUS and TDP-43
recruit additional protein partners and mRNA substrates
into stress granules, thereby further increasing their size
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and abundance (Figure 4 and [25,30]). Indeed, thousands
of mRNA transcripts are bound by FUS [58,59] with many
distinct mRNAs bound by cytoplasmic mutant-FUS but
not WT FUS [59]. Therefore, mutant-FUS may inappro-
priately process mRNAs and/or facilitate aberrant cyto-
plasmic protein interactions during stress. The latter
possibility is supported by our FRAP analyses, which
showed that both mRFP-G3BP and mRFP-TIA-1 exhibit
weaker binding and heightened dynamics within sodium
arsenite-induced stress granules containing mutant-FUS
(Figure 3). In fact, GFP-FUS R495X altered the dynamic
properties of stress granules in all of our FRAP experi-
ments, raising the possibility that mutant-FUS interferes
with the sorting mechanisms [21,22] associated with these
structures under stress.
If the association of mutant-FUS with stress granules
does indeed represent a gain of toxic interaction, it will be
important to identify factors that modulate this associ-
ation. Although FUS contains multiple domains that con-
tribute to FUS aggregation [60] and/or are homologous to
sequences that direct other proteins into stress granules
[26,50-52], our results show that the RGG domains are
largely responsible for directing FUS into stress granules
(Figure 5). Our results are in general agreement with a re-
cent report by Bentmann et al., which also demonstrated a
key role for the RGG domains in assembling FUS into
stress granules [26]. However, our results do not support a
role for the Gly-rich and RRM domains in this process,
whereas the former study did. This discrepancy may be
due to the difference in FUS constructs, stressor (sodium
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Figure 6 Methylation of mutant-FUS is not required for its assembly into stress granules. HeLa cells transfected with GFP-FUS R495X were
pre-treated with the methyltransferase inhibitor adenosine-2,3 dialdehyde (AdOx) and then exposed to sodium arsenite to promote stress granule
assembly. (A) GFP-FUS R495X was detected by western analysis only for immunoprecipitation (IP) reactions from transfected cells (GFP-FUS (+)).
Anti-GFP was used for both IP and western analyses. The ASYM24 antibody revealed that GFP-FUS R495X was hypomethylated on arginine
residues when cells were pre-treated with AdOx. (B) Confocal fluorescence images revealed a robust association of GFP-FUS R459X with sodium
arsenite-induced (SA(+)) stress granules, both in the absence (left panels) and presence (right panels) of AdOx. Conversely, the ASYM24 signal
within the same stress granule was dramatically attenuated when cells were pre-treated with AdOx. (C) Quantification of n=3 independent
experiments from (B) further supports the conclusions above. Statistical significance was determined by a Student’s t-test (** P < 0.01). All error
bars represent SEMs.
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arsenite versus heat shock [26]) and/or the FUS muta-
tion (R521G versus P525L [26]) that were employed in
these studies. Whether the RNA-binding ability of FUS
is required for its localization to stress granules is not
altogether clear [26,27]. Several domains within FUS ex-
hibit RNA-binding capabilities, including the RMM,
RGG, and zinc finger domains. Bentmann et al. demon-
strated a correlation between cytoplasmic FUS con-
structs that bound RNA and were incorporated into
stress granules, consistent with a role for RNA-binding
in the assembly of mutant-FUS into stress granules [26].
That the RGG domains direct mutant-FUS to stress
granules raises the possibly that this process is con-
trolled by arginine dimethylation of RGG motifs [61].
Emerging evidence indicates that the RGG motifs
within FUS are methylated by protein arginine N-
methyltransferase-1 (PRMT1) [55,62,63], and that this
post-translational modification can influence the sub-
cellular localization of mutant-FUS [62,63]. While stress
granules contain methylated proteins (Figure 6B), and
methylated forms of mutant-FUS have been detected in
both stress granules and diseased-tissues [5], our data
suggests that methylation of FUS is not a prerequisite
for its incorporation into stress granules (Figure 6).
How might the incorporation of mutant-FUS into stress
granules alter cellular homeostasis under conditions of in-
duced stress, and what are the implications for neurode-
generative disease? We show that mutant-FUS delays
stress granule assembly (Figures 1 and 2), decreases the
binding of stress granule-associated proteins within stress
granules (Figure 3), and increases both size and abundance
of stress granules (Figure 4). These physical and dynamic
properties of stress granules are thought to be linked to
stress granule function, and thus the effects of mutant-FUS
may culminate in impaired stress response and, eventually,
in neurodegeneration. Although there have been no re-
ports of overt cytotoxicity in mutant-FUS cellular models
exposed to sodium arsenite or other stressors, the effects
of impaired stress response may appear more distinctly as
a function of age, disease progression and/or chronic stress
in the human disease [19]. In fact, stress granule marker
proteins have been detected within the pathological inclu-
sions of CNS tissues from patients with ALS and FTLD
[6,25], supporting the notion that stress response factors
are altered during the course of disease. Moreover, these
observations raise the possibility that stress granules are
precursors to the end-stage aggregates that are characteris-
tic of these diseases [23]. Although our data show that
mutant-FUS accelerates stress granule disassembly, under
conditions of persistent stress these granules containing
mutant-FUS are larger and more numerous and thus have
the potential to coalesce into larger aggregates. Extending
analyses of stress granules to other models systems, such
as human iPS cells from individuals with ALS or ALS
rodent models, may allow us to better address whether al-
tered stress granule assembly plays a role in disease onset
and/or progression, and whether the association of ALS-
linked proteins with stress granules does in fact impact
disease.
Conclusions
ALS-linked FUS mutants that mislocalize to the cyto-
plasm not only incorporate into stress granules under
conditions of oxidative stress, but the presence of
mutant-FUS in stress granules alters the properties of
these structures. Expression of mutant-FUS delays the
assembly and expedites the disassembly of stress gran-
ules. Furthermore, the morphology and dynamics of
these structures is influenced by the presence of
mutant-FUS. Therefore, our data are consistent with a
gain of toxic function for mutant-FUS with respect to
stress granule assembly and dynamics.
Materials and methods
Cell culture and drug treatments
Inducible GFP-FUS expressing FlpIn HEK-293 cells were
maintained as described previously [13]. Human cervical
carcinoma cells (HeLa) were maintained in Modified Ea-
gle’s medium (MEM, Gibco 10370) supplemented with
10% (v/v) heat inactivated fetal bovine serum (Sigma,
F4135), 2 mM L-glutamine (Gibco, 25030), and 1% (v/v)
penicillin and streptomycin solution (Gibco, 15140).
Mouse motor neuron–like hybrid cell lines (NSC-34)
[38] constitutively expressing untagged human FUS
were maintained in Dulbecco’s modified Eagle’s medium
(Invitrogen, 11965118) supplemented with 10% (v/v)
tetracycline-tested fetal bovine serum (Sigma, F6178),
and 2 μg/mL puromycin (Invitrogen, A11138-03).
NSC-34 cells constitutively expressing untagged human
FUS constructs were generated by lentiviral transduction
of the CSCW2-IRES-GFP lentivector (a generous gift from
Dr. Miguel Esteves, University of Massachusetts Medical
School) containing FUS (WT or mutant R495X). Flow cy-
tometry was used to enrich for expression of the GFP
reporter in each line. Cells with equivalent levels of ex-
ogenous FUS proteins were employed.
For drug treatments, the following stocks were pre-
pared and stored at freezing temperatures: 50 mg/mL
doxycycline (Sigma, D9891) in water (−80°C), 100 mM
sodium arsenite (Sigma, 71287) in water (−20°C) and 20
mM adenosine-2,3 dialdehyde (“AdOx”; Sigma, A7154)
in water (−20°C). FUS expression in the FlpIn HEK-293
lines was induced with the addition of 1 μg/mL doxy-
cycline for 24 hrs unless otherwise noted. Cells were
then exposed to sodium arsenite and/or AdOx as de-
scribed below.
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Plasmids and cloning
The pEmRFP-G3BP and mRFP-TIA-1 plasmids for FRAP
analyses were generously provided by Drs. Nancy Kedersha
and Paul Anderson (Brigham and Women’s Hospital,
Harvard Medical School). The mRFP-TIA-1 was sub-
cloned into the low expression lentivirus vector CShPW2
(a gift from Miguel Estevez, UMMS) with NheI and Knp1
restriction sites using BP Clonase II (Invitrogen, 11789–
020), thereby creating CShPW2-RFP-TIA-1. MBP-M9M
was a kind gift from Dr. Yuh Min Chook (University of
Texas Southwestern Medical Center).
GFP-FUS R521G deletion constructs were constructed
as follows: PCR amplified full length GFP-FUS R521G,
flanked by attB homologous sequences, was cloned into
pDONR221 vector (Invitrogen, 12536–017) with BP
Clonase II (Invitrogen, 11789–020) to generate the starting
plasmid pDONR221:GFP-FUS R521G. To facilitate substi-
tution of the full length gene with deletion/truncation vari-
ants, restriction sites for KpnI and XbaI were introduced
upstream of the ATG start codon and downstream the
TAA stop codon, respectively, using the following primers:
fwd: GGGGACAAGTTTGTACAAAAAAGCAGGCTGG
TACCATGGCCTCAAACGATTATACCC, rev: GGGGA
CCACTTTGTACAAGAAAGCTGGGTTCTAGATTAAT
ACGGCCTCTCCCTGC. To generate deletion constructs,
the following primers were designed by joining the up-
stream and downstream sequences flanking the domain
that was deleted: ΔGLY_fwd: AGAACCAGTACAACAG
CAGCAGTACCATCTTTGTGCAAGGCC; ΔGLY_rev:
ACTCAATTGTAACATTCTCACCCAGACTGCCAGA
CAACAACACCCGGGCAGACTTTAATCGGG; ΔRR
M_rev: CCACGACCATTGCCACCACCGTTGTTGTC
TGAATTATCCTGTTCG; ΔRGG1_fwd: CAAGGTCT
CATTTGCTACTCGCGCTGGTGACTGGAAGTGTCC;
ΔRGG1_rev: CATATTCTCACAGGTGGGATTAGGCC
GATTAAAGTCTGCCCGGC; ΔRGG2_fwd: CCAGTGT
AAGGCCCCTAAACCAGATAAGATGGATTCCAGGGG
TGAGCAC; ΔRGG2_rev: GTGCTCACCCCTGGAATC
CATCTTATCTGGTTTAGGGGCCTTACACTGG; Δ422-
526_fwd: GGGGACAAGTTTGTACAAAAAAGCAGGC
TGGTACCATGGCCTCAAACGATTATACCC; Δ422-
526_rev: GGGGACCACTTTGTACAAGAAAGCTGG
GTTCTAGATTATCGCTGCTGTCCTCCACC. The de-
letion reactions were performed using the pDONR221:
FUS R521G plasmid as template and the QuikChange II
Mutagenesis kit (Stratagene; 200523) according to the
manufacturer’s instructions. For the ΔQGSY truncation
construct, PCR was performed using a reverse primer for
the full-length R521G gene paired with a forward primer
containing the 5’-end sequences of ΔGLY flanked by the re-
striction enzyme KpnI recognition sequence: ΔQGSY_fwd:
CAGGCTGGTACCGGTGGTGGAGGTGGAGGT. All
constructs were then sub-cloned into the expression
vector pDEST-53 (Invitrogen) using Gateway cloning
method with LR Clonase II (Invitrogen, 11791–100)
according to the manufacturer’s instructions.
Immunofluorescence
Standard immunofluorescence protocols were employed as
described previously [13]. Briefly, cells were fixed with 4%
paraformaldehyde for 10–15 min then blocked with PBSAT
(1X PBS/1% BSA/0.5% Triton-X 100) for 30–60 min at am-
bient temperature. Primary antibodies described in each ex-
periment were diluted in PBSAT and applied to cells at
ambient temperature for 1 hr. Primary antibody dilutions
were as follows: 1:2000 for mouse anti-G3BP (BD Trans-
duction Labs, 611126), 1:1000 for rabbit anti-G3BP
(Proteintech, 130-57-2AP), 1:1500 for rabbit anti-dimethyl
arginine (“ASYM24”; Millipore, 07–414) and 1:200 mouse
anti-FUS (Santa Cruz, SC-4771). Cells were then incubated
with secondary antibodies diluted 1:1000–1:2500 in PBSAT
for 45 min at ambient temperature. Secondary antibodies
included Dylight 549 conjugated anti-mouse IgG (Jackson
ImmunoResearch Labs, 715-505-151), Cy3 conjugated anti-
mouse IgG (Jackson ImmunoResearch Labs, 715-165-151),
Cy3 conjugated anti-rabbit IgG (Jackson ImmunoResearch
Labs, 711-165-152), and Cy5 conjugated anti-mouse IgG
(Jackson ImmunoResearch Labs, 715-175-151). GFP signal
was enhanced by 1:1000 dilution of Alexa Fluor 488-
conjugated rabbit anti-GFP (Invitrogen, A21311). Cells
were stained with 34 ng/mL DAPI in dH2O, and coverslips
were mounted with ProLong Gold anti-fade reagent
(Invitrogen, P36930).
Western blotting
Standard western blotting protocols were employed as de-
scribed previously [13]. Primary antibodies described in
each experiment were diluted as follows: 1:1000 for mouse
anti-GFP (Living Colors; Clontech, 632380), 1:1000 for
rabbit anti-dimethyl-arginine (“ASYM24”; Millipore, 07–
414), 1:1000 for mouse anti-tubulin (Sigma, T9026), and
1:1000 for rabbit anti-FUS. Rabbit anti-FUS antibodies
were generated by GenScript against a C-terminal epitope,
using the peptide CKFGGPRDQGSRHDSEQDNSD. Blots
were incubated with primary antibodies for 1 hr at ambi-
ent temperature or overnight at 4°C. Secondary antibodies,
including anti-mouse IRDye 680 (Licor, 926–32220) or
IRDye 800 (LiCor, 926–32210) and anti-rabbit IRDye 680
(LiCor, 926–32220) or IRDye 800 (Licor, 926–32211),
were diluted 1:10000 and incubated with blots for 1–2 hrs
at ambient temperature. Bands were visualized with an
Odyssey Infrared Imager (LiCor, Model 9120), and densi-
tometry measurements performed with the Odyssey Soft-
ware (LiCor, V3.0).
Stress granule assembly and disassembly kinetics
Inducible GFP-FUS (WT, R495X and H517Q) HEK-293
cells were plated on coverslips at a density of 5 × 104
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cells/coverslip. The next day, GFP-FUS expression was
induced as described above. For stress granule assembly
measurements, cells were treated with 0.25 mM sodium
arsenite for 40 or 90 min. Coverslips were then fixed
and processed for immunofluorescence (IF) with the
mouse anti-G3BP and rabbit anti-GFP antibodies listed
above. For stress granule disassembly measurements,
cells were treated with 0.25 mM sodium arsenite for 60
min, at which time the media containing sodium arse-
nite was replaced with fresh media. After 90 min in fresh
media, cells were processed for IF as described above.
The percentage of cells with stress granules was deter-
mined as [(the number of cells containing at least one
stress granule / total number of cells) × 100]. More than
2000 healthy, interphase, non-crowded cells were counted
in multiple (between n=4 and n=11, depending on cell line
and condition) independent experiments for both assem-
bly and disassembly conditions. A one-way ANOVA with
Tukey's multiple comparisons post-test was used to com-
pare the induced and uninduced groups. Similar parame-
ters were used for assembly kinetics in NSC-34 parent
cells and cells expressing untagged human FUS proteins
with the following changes: cells were treated with sodium
arsenite for 1 hr, and immunofluorescence was performed
with the rabbit anti-G3BP and mouse anti-FUS antibodies
listed above. More than 2000 cells were counted in at least
n=11 independent experiments per condition. Statistical
significance was determined by one-way ANOVA with
Tukey's multiple comparisons post-test.
Fluorescence recovery after photobleaching
GFP-FUS WT and GFP-FUS R495X HEK-293 cells were
plated at a density of 8 ×104 cells/plate in 35 mm glass bot-
tom dishes (MatTek Corp, P35GC-1.5-14-C), allowed to
adhere for 48 hrs, then transfected with either CShPW2-
RFP-TIA-1 or pEmRFP-G3BP expression plasmids using
Lipofectamine 2000 (Invitrogen, 11668–019) according to
the manufacturer’s instructions with a 1.6 μl Lipo: 3.2 μg
DNA ratio. Approximately 23 hr post-transfection, phenol
red(−) growth media without (overexpression experiments)
or containing 0.2 mM sodium arsenite (stress granule ex-
periments) was applied to the cells for 1 hr prior to FRAP.
FRAP experiments were performed at 37°C as previ-
ously described [45]. Multiple cells were analyzed in each
experiment over a 30 min period starting at 60 min of so-
dium arsenite exposure. Experiments were carried out on
a Leica SP5 AOBS laser scanning confocal microscope
using a 40× 1.3NA water immersion objective or a Leica
SP1 system using a 40×, 1.25NA oil immersion objective.
No more than two stress granules, from opposite sides of
a cell, were individually bleached using a 1-3s laser pulse
delivered by a 488 nm or 561 nm laser. A pre-bleach, im-
mediate post-bleach and 16 additional post-bleach images
spaced at 5 sec intervals were captured. Leica Confocal
Software (Leica Microsystems, Exton, PA) was used to
measure fluorescence intensity in the bleached region of
interest (ROI), the whole cell, and in a background control
area lacking cells at each time point. The data was ana-
lyzed and background fluorescence subtracted using Excel.
The relative fluorescence intensity (Irel) in the bleached
area was calculated as previously shown [45]. Briefly, the
following equation was used: Irel, t = (It × (C0/Ct))-(Ipbl ×
(C0/Cbl))/(I0-(Ipbl × (C0/Cpbl)), where C0 is the total cellular
fluorescence before bleaching, Cpbl is the total cellular
fluorescence in the post-bleach image, Ct is the total cellu-
lar fluorescence at time t, I0 is the pre-bleach ROI fluores-
cence intensity, It is the ROI fluorescence intensity at
time t, and Ipbl is the post-bleach ROI fluorescence inten-
sity. The data was normalized using this equation such
that the post-bleach ROI fluorescence intensity was set to
0 and the pre-bleach ROI fluorescence intensity to 1. It
was calculated as the percentage difference between the
relative fluorescence asymptote of the recovery curve and
a relative recovery of 1, a value that would reflect complete
recovery without an immobile fraction. Recovery curves
were drawn using Graphpad Prism 6 (Graphpad Software),
with individual time points presented as means ± SEMs.
Fluorescence recovery half times were calculated from ex-
ponential one-phase association curves best fit for the re-
covery graphs: F(t) = Fmax (1- e
-kt). Mobile fractions were
calculated from the plateau region from each curve, which
was identified as the series of data points with < 2% change
in slope over time.
At least two independent experiments were performed
for all conditions. The total number of stress granules ana-
lyzed for each condition is shown in Figure 3. A two-way
ANOVA was used to determine statistical significance be-
tween the mobile fractions for each of the experiments.
Morphology experiments
Stable GFP-FUS HEK-293 cells were plated and processed
for immunofluorescence as described under ‘stress granule
assembly and disassembly kinetics’ above, except that cells
were treated with 0.5 mM sodium arsenite for 1 hr. Con-
focal stacked images (0.2 μm stack step, 4 μm range) were
acquired using a Zeiss Axiovert 200 microscope with a
PerkinElmer UltraView LAS spinning disc equipped with a
100× phase objective. Imaris analytical software (Bitplane
Scientific Software) was used to construct 3D projections
of image stacks. Volume measurements were taken of each
stress granule with a G3BP fluorescence signal that was at
least 2-fold above background. Because P-bodies had an
average volume of 0.5 μm3 (data not shown) by the same
analysis, only stress granules with a volume > 0.5 μm3 were
included in the analysis. Data is averaged from three inde-
pendent experiments per line, using approximately 30
stress granules per condition. Statistical significance was
determined using the Student’s t-test.
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Analysis of FUS deletion constructs in stress granule
assembly
HeLa cells were plated on coverslips at a density of 2.5 ×
104 cells/coverslip and adhered at 37˚C for 24 hrs, after
which GFP-FUS R521G truncation constructs and MBP-
M9M were transiently transfected into cells using
Lipofectamine-2000 (Invitrogen, 11668) according to the
manufacturer’s instructions. Twenty-four hours post
transfection, cells were subjected to media containing 0.5
mM sodium arsenite for 1 hr. Cells were processed im-
munofluorescence with mouse anti-G3BP as described
above.
Confocal microscopy was performed using a Solamere
Technology Group CSU10B spinning disk confocal system
equipped with a Yokogawa CSU10 spinning disk confocal
scan head. Image stacks (0.2 μm stack step; 13 stack
range) were acquired using a 100× oil objective, a Roper
Cool-snap HQ2 camera and MetaMorph V7.6.3 software.
Background signal was subtracted by removing fluores-
cence from a dark-current image (acquired with the laser
off) from each raw image. For the GFP images, variations
in illumination and detection efficiencies at each pixel
were corrected by dividing the dark-adjusted intensities by
a normalized flat-field image of a uniformly green fluores-
cent slide (Chroma Technology, Rockingham, VT, USA)
acquired using the same 525/50 nm band-pass filter. Four
channels were imaged per cell: FITC for GFP-FUS, Cy3
for G3BP, DAPI for nuclei and phase for cell borders.
The extent of GFP-FUS incorporation into stress gran-
ules was analyzed with MetaMorph V7.6.3 software
using the Integrated Morphometry Analysis tool. Since
cells with a GFP signal brighter than 1.5 × 106 grays/μm2
tended to form cytoplasmic aggregates a priori of arse-
nite treatment (data not shown), only transfected cells
with GFP-FUS expression levels < 1.5 × 106 grays/μm2
were selected for analysis. Stress granules were selected
using the Cy3 (G3BP) channel as a reference. The slice
corresponding to the center of the stress granule was se-
lected from each image stack. Stress granules with an
area of at least 0.5 μm2 were selected. An outline was
drawn around each G3BP granule, and this outline was
then transferred to the corresponding FITC (GFP-FUS)
image, such that the GFP-FUS signal intensity (“stress
granules intensity”) within that granule could be mea-
sured. GFP signal intensity measurements were also ac-
quired in the region proximal to the stress granule, and
was referred to as the “Diffuse intensity”. The ratio of
stress granule intensity (i.e., GFP-FUS inside the stress
granule) to diffuse intensity (i.e., GFP-FUS outside the
stress granule) was determined for a total of 75–150
stress granules per construct over three independent ex-
periments. Statistical significance was determined by a
one-way ANOVA followed by a Dunnett’s post hoc test
in Graphpad Prism 6 (Graphpad software).
Methyltransferase inhibition studies
HeLa cells were plated at a density of 2.5 × 104 cells/
coverslip and adhered for 24 hrs, after which GFP-FUS
R495X expression constructs were transiently transfected
with Lipofectamine-2000 either with or without 25 μM
AdOx for 24 hr. Cells were then exposed to 0.5 mM so-
dium arsenite for 1 hr, and coverslips were processed for
immunofluorescence using the mouse anti-G3BP rabbit
and ASYM24 antibodies as described above. For quantifi-
cation, confocal images of 30 cells per condition across
three independent experiments were taken, and the inten-
sity of GFP-FUS and ASYM24 signal within stress gran-
ules was determined between AdOx-treated and untreated
conditions using MetaMorph as described above. Statis-
tical significance was determined using a Student’s t-test.
For GFP immunoprecipitation (IP) reactions, cells
were lysed for 15 min in IP buffer (400 μL 1% NP-40
(MP Biomedicals, 198596)/50 mM Tris–HCl (Sigma
T3253-500G)/5 mM EDTA (Fisher E478-500)/150 mM
NaCl and 10% v/v glycerol (Acros 15982–0010) in
water; pH 7.5), and centrifuged at 13000 rpm for 15 min
at 4°C. The supernatant was pre-cleared with 50 μL
Biomag Protein G beads (Qiagen, 311812) for 2 hrs at 4°C.
Anti-GFP-coated beads for each sample were prepared by
incubating 0.5 μL of anti-GFP (Abcam, ab290) in 400 μL
of IP buffer with 50 μL Biomag Protein G beads for 2 hrs
at 4°C. IP reactions were performed at 4°C overnight with
100 μg of pre-cleared lysate. Protein elution was accom-
plished with 50 μL 1X SDS loading buffer (Boston
Bioproducts BP11R) for 5 min at 95°C, and 20 μL of
sample was subjected to western blot analysis with mouse
anti-GFP, mouse anti-tubulin and ASYM24 as described
above.
Additional files
Additional file 1: A minor fraction of GFP-FUS H517Q incorporates
into stress granules in response to sodium arsenite. Images for the
indicated GFP-FUS cell line (top 3 rows) were collected as described in
Figure 1A. Antibody markers used for immunofluorescence are indicated
on the left. Images overexposed for GFP detection (bottom row) reveal
that a minor fraction of GFP-FUS H517Q (green) co-localizes with G3BP-
positive stress granules (red). FUS H517Q containing stress granules are
denoted by arrows. Conversely, GFP-FUS WT is not detected in stress
granule (i.e., there is no GFP-positive signal that co-localized with G3BP),
even with high exposure. Scale bar = 5 μm.
Additional file 2: NSC-34 cells expressing untagged human FUS WT
and R495X exhibit similar transduction efficiencies. Fluorescent
images of the GFP reporter (green) in NSC-34 cells transduced with
lentivirus containing untagged human FUS WT or R495X. Transduction
efficiencies of approximately 100% were determined for both lines.
Cellular nuclei are stained with DAPI (blue). Scale bar = 20 μm.
Additional file 3: Sodium arsenite induced stressed granules
display different dynamics compared to those induced by mRFP-
G3BP over-expression. (A) Transfection of mRFP-G3BP was sufficient to
induce G3BP positive stress granules in a subset of both GFP-FUS WT and
GFP-FUS R495X cells as determined by live cell imaging. Scale bar = 20
μm. (B) The FRAP recovery curve for mRFP-G3BP inside the stress granule
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in (A) was different depending on whether mRFP-G3BP was transfected into
GFP-FUS WT (blue circle) or R495X (red square) expressing cells. Note the
trend is opposite from sodium arsenite-induced stress granule in Figure 3.
(C) Quantification of the mobile fraction from the recovery curves in (B)
compared to those in Figure 3G revealed that expression of GFP-FUS R495X
significantly increased mRFP-G3BP binding (i.e., smaller mobile fraction) to
stress granules in the over-expression condition compared to all other
conditions. Asterisks indicate statistically significant differences between cell
lines as determined by two-way ANOVA (****P < 0.0001) on data from n=3
independent experiments. Additional significant comparisons include, but
are not shown for clarity: WT in the overexpression versus WT in the sodium
arsenite condition (P < 0.05); R495X in the overexpression versus R495X in
the sodium arsenite condition (P < 0.0001); R495X in the overexpression
versus WT in the sodium arsenite condition (P < 0.05). The total number (N)
of stress granules analyzed is indicated. All error bars represent SEMs.
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